Abstract: An apparatus for aerosol delivery, wherein the apparatus includes an outer body, a power source, an aerosolizable material reservoir, a control circuit containing an aerosol generation mechanism, and a processing circuit configured to send identification data associated with the apparatus to an external device, receive an external response from the external devices, wherein the external response is generated as a function of the identification data by the external device, modify an internal state of the processing circuit as a function of the external response, determine a device usability as a function of the modified internal state, and configure the control circuit as a function of the device usability.

Abstract: A system for initiating a recycling program of consumer electronic devices, wherein the system includes a collection device configured to collect a plurality of consumer electronic devices from users, a processing unit located within a permitted facility, communicatively connected to the collection device, wherein the processing unit is configured to disassemble each consumer electronic device of the plurality of consumer electronic devices into a plurality of base components through an electronic device disassembling process, wherein the plurality of base components includes a plurality of plastic components and at least a battery component, process the plurality of base components, wherein processing the plurality of base components includes disintegrating the plurality of plastic components into a plurality of granules and decomposing the at least one battery component into a plurality of electrochemical materials, and generate a recycled output using the processed plurality of base components.

Abstract: The present invention relates to compounds (reactive conjugates) for the chemical modification of therapeutic antibodies or proteins. The compounds enable the regioselective attachment of payloads to an antibody or antibody fragment in one single step, thereby producing a modified antibody or modified antibody fragment, which can be used for diagnosing, monitoring, imaging or treating disease.

Abstract: A 68Ga-labeled gastrin analogue and its use in peptide receptor radionuclide diagnostic applications is provided. In particular, a 68Ga-labeled minigastrin analogue for use in a method of imaging one or more cholecystokinin B receptor positive diseases selected from small-cell lung cancer, extrapulmonary small-cell carcinoma and medullary thyroid cancer is provided. A kit including the gastrin analogue is also provided.

Abstract: The present invention relates to compounds (reactive conjugates) for the chemical modification of therapeutic antibodies or proteins. The compounds enable the regioselective attachment of a payload to an antibody or antibody fragment in one single step, thereby producing a modified antibody or modified antibody fragment, which can be used for diagnosing, monitoring, imaging or treating disease.

Abstract: A time accounting system for accounting parking subject to charge periods which includes a card having an electronic memory in which each memory location can be individually and irreversibly written in order to represent a time unit credit allocated to the holder of the card. The system also includes a portable case in which the card can be inserted and which has an internal clock circuit and a coupling circuit, as well as a writing circuit. The case is designed with means for temporary storage of a time unit credit which is activable if the time credit remaining in the inserted card is less than the parking time of the holder.